morpholinoanthracycline mx2 has been researched along with Glioma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabuto, M; Kitai, R; Kobayashi, H; Kubota, T; Nakagawa, T | 1 |
| Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Uno, H | 1 |
| Arai, Y; Kabuto, M; Kitai, R; Kobayashi, H; Kubota, T; Nakagawa, T | 1 |
| Fujita, H; Kawamoto, K; Kiya, K; Kurisu, K; Ogasawara, H; Shinkai, H; Sugiyama, K; Uozumi, T | 1 |
| Furuta, T; Matsumoto, K; Mizumatsu, S; Ohmoto, T; Ono, Y; Tamiya, T | 2 |
| Arita, N; Hayakawa, T; Kuratsu, J; Kurisu, K; Uozumi, T; Ushio, Y | 1 |
| Hill, JS; Kaye, AH; Park, SJ | 1 |
| Mima, T; Mori, K; Mostafa, MG | 1 |
| Kochi, M; Kuratsu, J; Mihara, Y; Takaki, S; Ushio, Y | 1 |
| Arita, N; Hayakawa, T; Izumoto, S; Komeshima, N; Mogami, H; Ohnishi, T; Oku, Y; Taki, T; Ushio, Y; Yamamoto, H | 1 |
1 trial(s) available for morpholinoanthracycline mx2 and Glioma
| Article | Year |
|---|---|
A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Brain Neoplasms; Carubicin; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1999 |
10 other study(ies) available for morpholinoanthracycline mx2 and Glioma
| Article | Year |
|---|---|
The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
Topics: Animals; Antibiotics, Antineoplastic; Brain; Brain Neoplasms; Carubicin; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Glioma; Humans; Male; Microscopy, Electron; Neoplasm Transplantation; Rats; Rats, Wistar; Subcellular Fractions; Tissue Distribution; Tumor Cells, Cultured | 1995 |
[Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Glioma; Photochemotherapy; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1995 |
Subcellular localization and cellular pharmacokinetics of MX2, a new morpholino anthracycline in glioma cells using confocal laser scanning microscopy.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Carubicin; Cell Line; Doxorubicin; Glioma; Humans; Male; Microscopy, Confocal; Microscopy, Electron; Rats; Rats, Wistar; Subcellular Fractions; Time Factors | 1994 |
[Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
Topics: Animals; Antibiotics, Antineoplastic; Brain; Brain Neoplasms; Carubicin; Cell Division; Female; Glioma; Neoplasm Transplantation; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1993 |
[Combination effect of hyperthermia and MX2 on cultured glioma cell lines].
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Cell Survival; Coloring Agents; Combined Modality Therapy; Culture Media; Glioma; Humans; Hyperthermia, Induced; Rats; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1999 |
An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Carubicin; Cell Division; Glioma; Humans; Lipoproteins; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |
Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Carubicin; Dose-Response Relationship, Drug; Feasibility Studies; Glioma; Injections, Intraventricular; Injections, Spinal; Male; Nervous System Diseases; Rats; Rats, Wistar; Survival Analysis | 2000 |
Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: a comparative analysis using rodent models of gliomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Brain Edema; Brain Neoplasms; Carubicin; Disease Models, Animal; Doxorubicin; Glioma; Leukocyte Count; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nimustine; Rats; Survival Rate | 2000 |
[Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Cell Line; Doxorubicin; Glioma; Humans; In Vitro Techniques; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1989 |
[Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
Topics: Animals; Antibiotics, Antineoplastic; Arachnoid; Brain Neoplasms; Carubicin; Female; Glioma; Humans; Meningeal Neoplasms; Naphthacenes; Pia Mater; Rats; Rats, Inbred Strains | 1988 |